If he can move 1.5 million viles of inventory in bulk . It’s very doable , plus the dividends are one of his “hooks” to keep retail investors going. But it’s very possible if he moves the compete inventory which I believe will happen in one or two orders. He doesn’t have develop,ent costs because the drug is already developed. It’s purely cost to run the business and clinical trials .